
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE53454F8AF4348305454F0010103B11.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cii">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancer Immunology, Immunotherapy : CII">
<meta name="citation_title" content="Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity">
<meta name="citation_author" content="Yoichiro Narikawa">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Atsuo Kuramasu">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author" content="Masahiro Hosonuma">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Masakazu Murayama">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Eiji Funayama">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Division of Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Akiko Sasaki">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Yuta Baba">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author" content="Hitoshi Toyoda">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Department of Orthopedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Junya Isobe">
<meta name="citation_author_institution" content="Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Kohei Tajima">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author" content="Rie Nakashima">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author" content="Aya Sasaki">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Yuki Maruyama">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Yoshitaka Yamazaki">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa Medical University School of Pharmacy, Tokyo, Japan">
<meta name="citation_author" content="Midori Shida">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author" content="Toshiaki Tsurui">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Yuya Hirasawa">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Hirotsugu Ariizumi">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Tomoyuki Ishiguro">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Risako Suzuki">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Ryotaro Ohkuma">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Yutaro Kubota">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Takehiko Sambe">
<meta name="citation_author_institution" content="Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Mayumi Tsuji">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Satoshi Wada">
<meta name="citation_author_institution" content="Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Atsushi Horiike">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Shinichi Kobayashi">
<meta name="citation_author_institution" content="Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Takuya Tsunoda">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Sei Kobayashi">
<meta name="citation_author_institution" content="Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan">
<meta name="citation_author" content="Hitome Kobayashi">
<meta name="citation_author_institution" content="Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author" content="Tatsunori Oguchi">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Toshikazu Shimane">
<meta name="citation_author_institution" content="Head and Neck Oncology Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Yuji Kiuchi">
<meta name="citation_author_institution" content="Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_author_institution" content="Pharmacological Research Center, Showa Medical University, Tokyo, Japan">
<meta name="citation_author" content="Kiyoshi Yoshimura">
<meta name="citation_author_institution" content="Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="74">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="289">
<meta name="citation_doi" content="10.1007/s00262-025-04111-2">
<meta name="citation_pmid" content="40828195">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/pdf/262_2025_Article_4111.pdf">
<meta name="description" content="Inosine, a bacterial metabolite and agonist of the adenosine A2A receptor, modulates antitumor immunity. However, its precise effects on immune checkpoint inhibitors remain unclear. This study aimed to evaluate the impact of inosine on the efficacy ...">
<meta name="og:title" content="Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Inosine, a bacterial metabolite and agonist of the adenosine A2A receptor, modulates antitumor immunity. However, its precise effects on immune checkpoint inhibitors remain unclear. This study aimed to evaluate the impact of inosine on the efficacy ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12364772">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s00262-025-04111-2"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/262_2025_Article_4111.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364772%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12364772/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12364772/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cii.png" alt="Cancer Immunology, Immunotherapy : CII logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cancer Immunology, Immunotherapy : CII" title="Link to Cancer Immunology, Immunotherapy : CII" shape="default" href="https://doi.org/10.1007/s00262-025-04111-2" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancer Immunol Immunother</button></div>. 2025 Aug 19;74(9):289. doi: <a href="https://doi.org/10.1007/s00262-025-04111-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s00262-025-04111-2</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cancer%20Immunol%20Immunother%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer%20Immunol%20Immunother%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer%20Immunol%20Immunother%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancer%20Immunol%20Immunother%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Narikawa%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yoichiro Narikawa</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yoichiro Narikawa</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>4</sup>Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Narikawa%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yoichiro Narikawa</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kuramasu%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Atsuo Kuramasu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Atsuo Kuramasu</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kuramasu%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Atsuo Kuramasu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hosonuma%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Masahiro Hosonuma</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Masahiro Hosonuma</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hosonuma%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masahiro Hosonuma</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murayama%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Masakazu Murayama</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Masakazu Murayama</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>4</sup>Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murayama%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masakazu Murayama</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Funayama%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Eiji Funayama</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Eiji Funayama</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>14</sup>Division of Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Funayama%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eiji Funayama</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sasaki%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Akiko Sasaki</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Akiko Sasaki</span></h3>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sasaki%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Akiko Sasaki</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baba%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yuta Baba</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yuta Baba</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baba%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuta Baba</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toyoda%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Hitoshi Toyoda</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Hitoshi Toyoda</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>7</sup>Department of Orthopedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toyoda%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hitoshi Toyoda</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Isobe%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Junya Isobe</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Junya Isobe</span></h3>
<div class="p">
<sup>8</sup>Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Isobe%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Junya Isobe</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tajima%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Kohei Tajima</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Kohei Tajima</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tajima%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kohei Tajima</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nakashima%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Rie Nakashima</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Rie Nakashima</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nakashima%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rie Nakashima</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sasaki%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Aya Sasaki</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Aya Sasaki</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sasaki%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aya Sasaki</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maruyama%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Yuki Maruyama</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Yuki Maruyama</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maruyama%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuki Maruyama</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yamazaki%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Yoshitaka Yamazaki</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Yoshitaka Yamazaki</span></h3>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>9</sup>Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa Medical University School of Pharmacy, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yamazaki%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yoshitaka Yamazaki</span></a>
</div>
</div>
<sup>3,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shida%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Midori Shida</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Midori Shida</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shida%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Midori Shida</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsurui%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Toshiaki Tsurui</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Toshiaki Tsurui</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsurui%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Toshiaki Tsurui</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hirasawa%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Yuya Hirasawa</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Yuya Hirasawa</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hirasawa%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuya Hirasawa</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ariizumi%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Hirotsugu Ariizumi</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Hirotsugu Ariizumi</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ariizumi%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hirotsugu Ariizumi</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ishiguro%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Tomoyuki Ishiguro</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Tomoyuki Ishiguro</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ishiguro%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tomoyuki Ishiguro</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suzuki%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Risako Suzuki</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Risako Suzuki</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suzuki%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Risako Suzuki</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ohkuma%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Ryotaro Ohkuma</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Ryotaro Ohkuma</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ohkuma%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ryotaro Ohkuma</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kubota%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Yutaro Kubota</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Yutaro Kubota</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kubota%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yutaro Kubota</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sambe%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Takehiko Sambe</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Takehiko Sambe</span></h3>
<div class="p">
<sup>10</sup>Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sambe%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Takehiko Sambe</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsuji%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Mayumi Tsuji</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Mayumi Tsuji</span></h3>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsuji%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mayumi Tsuji</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wada%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Satoshi Wada</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Satoshi Wada</span></h3>
<div class="p">
<sup>11</sup>Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wada%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Satoshi Wada</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Horiike%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Atsushi Horiike</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Atsushi Horiike</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Horiike%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Atsushi Horiike</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Shinichi Kobayashi</span></a><div hidden="hidden" id="id27">
<h3><span class="name western">Shinichi Kobayashi</span></h3>
<div class="p">
<sup>12</sup>Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shinichi Kobayashi</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsunoda%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Takuya Tsunoda</span></a><div hidden="hidden" id="id28">
<h3><span class="name western">Takuya Tsunoda</span></h3>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsunoda%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Takuya Tsunoda</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id29"><span class="name western">Sei Kobayashi</span></a><div hidden="hidden" id="id29">
<h3><span class="name western">Sei Kobayashi</span></h3>
<div class="p">
<sup>6</sup>Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sei Kobayashi</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id30"><span class="name western">Hitome Kobayashi</span></a><div hidden="hidden" id="id30">
<h3><span class="name western">Hitome Kobayashi</span></h3>
<div class="p">
<sup>4</sup>Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hitome Kobayashi</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oguchi%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id31"><span class="name western">Tatsunori Oguchi</span></a><div hidden="hidden" id="id31">
<h3><span class="name western">Tatsunori Oguchi</span></h3>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oguchi%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tatsunori Oguchi</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shimane%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id32"><span class="name western">Toshikazu Shimane</span></a><div hidden="hidden" id="id32">
<h3><span class="name western">Toshikazu Shimane</span></h3>
<div class="p">
<sup>13</sup>Head and Neck Oncology Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shimane%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Toshikazu Shimane</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kiuchi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id33"><span class="name western">Yuji Kiuchi</span></a><div hidden="hidden" id="id33">
<h3><span class="name western">Yuji Kiuchi</span></h3>
<div class="p">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kiuchi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuji Kiuchi</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yoshimura%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id34"><span class="name western">Kiyoshi Yoshimura</span></a><div hidden="hidden" id="id34">
<h3><span class="name western">Kiyoshi Yoshimura</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div class="p">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yoshimura%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kiyoshi Yoshimura</span></a>
</div>
</div>
<sup>1,</sup><sup>5,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577 Japan </div>
<div id="Aff2">
<sup>2</sup>Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div id="Aff3">
<sup>3</sup>Pharmacological Research Center, Showa Medical University, Tokyo, Japan </div>
<div id="Aff4">
<sup>4</sup>Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div id="Aff5">
<sup>5</sup>Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div id="Aff6">
<sup>6</sup>Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan </div>
<div id="Aff7">
<sup>7</sup>Department of Orthopedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan </div>
<div id="Aff8">
<sup>8</sup>Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan </div>
<div id="Aff9">
<sup>9</sup>Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa Medical University School of Pharmacy, Tokyo, Japan </div>
<div id="Aff10">
<sup>10</sup>Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan </div>
<div id="Aff11">
<sup>11</sup>Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan </div>
<div id="Aff12">
<sup>12</sup>Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan </div>
<div id="Aff13">
<sup>13</sup>Head and Neck Oncology Center, Showa Medical University, Tokyo, Japan </div>
<div id="Aff14">
<sup>14</sup>Division of Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa Medical University, Tokyo, Japan </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Aug 29; Accepted 2025 Jun 4; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12364772Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40828195/" class="usa-link">40828195</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Inosine, a bacterial metabolite and agonist of the adenosine A2A receptor, modulates antitumor immunity. However, its precise effects on immune checkpoint inhibitors remain unclear. This study aimed to evaluate the impact of inosine on the efficacy of anti-programmed cell death protein 1 (PD-1) therapy and explore strategies to counteract any potential inhibitory effects. In in vitro co-culture systems, inosine selectively suppressed cancer cell growth without impairing T-cell viability. In a murine subcutaneous tumor model, inosine treatment reduced tumor growth and was associated with elevated interferon-gamma levels in the tumor microenvironment, along with increased infiltration by tumor-infiltrating lymphocytes and enhanced splenic CD4âº and CD8âº T-cell frequencies. However, the combination of inosine with anti-PD-1 therapy attenuated the antitumor effect and increased cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) expression in splenic T cells compared to levels after anti-PD-1 monotherapy. To overcome this inhibitory effect, we tested whether adding an anti-CTLA-4 antibody could restore antitumor immunity. Notably, the combination of inosine with both anti-PD-1 and anti-CTLA-4 antibodies significantly enhanced antitumor efficacy. These findings suggest that inosine may synergize with dual ICI therapy and represent a promising adjunct to improve immunotherapeutic outcomes.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s00262-025-04111-2.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Inosine, PD-1, CTLA-4, Immune checkpoint inhibitor, Tumor microenvironment</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par11">Immune checkpoint inhibitors (ICIs) attack cancer cells through the host immune system. In certain patients, ICIs remain effective even after treatment discontinuation. However, the efficacy of ICIs is currently approximately 10â€“20%, and enhancing their efficacy is a challenge [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. The efficacy of ICIs depends on the tumor microenvironment (TME). Therefore, targeting the TME is necessary to enhance the efficacy of ICIs [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par12">Gut microbiota significantly influences host immune function and can regulate the TME [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. The dynamic interaction between the gut microbiota and TME facilitates the activation of immune cells and creates a favorable environment for them to attack cancer cells, which is crucial for ICI efficacy [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. The efficacy of ICI depends on the host gut bacteria [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>â€“<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>], which modulates host immune functions through its metabolites. Intestinal bacteria degrade undigested products to produce metabolites, such as short-chain fatty acids, which influence the host immune function [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>â€“<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p>
<p id="Par13">Inosine, a nucleoside produced by intestinal bacteria such as <em>Bifidobacterium</em>, is involved in host immune function and enhances ICI therapy [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>â€“<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. It exerts antitumor effects by modulating the immune responses in the TME [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. However, the immune-mediated antitumor effects of inosine and the efficiency of ICI treatment combined with inosine remain unclear.</p>
<p id="Par14">In this study, the antitumor effects of inosine were assessed using both in vitro and in vivo models. Our results demonstrated the potential of a novel inosine combination therapy to maximize ICI efficacy.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par15">The human oral cancer cell line T3M-1 Clone2 (RRID:CVCL_8762) was provided by the RIKEN BioResource Research Center through the National BioResource Project of MEXT, Japan. The mouse colon cancer cell line CT-26 (RRID:CVCL_7254) was purchased from the American Tissue Culture Collection (Manassas, VA, USA). CT-26 and T3M-1 Clone2 were cultured in RPMI-1640 medium (Fujifilm, Tokyo, Japan) and Hamâ€™s F-10 nutrient mix (Thermo Fisher Scientific, Waltham, MA, USA), respectively, supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific) and 1â€‰Ã—â€‰penicillin/streptomycin (Thermo Fisher Scientific).</p></section><section id="Sec4"><h3 class="pmc_sec_title">T-cell activation and proliferation</h3>
<p id="Par16">Peripheral blood mononuclear cells (PBMCs) were isolated from the peripheral blood of healthy donors using Ficoll-Paque PLUS (Cytiva, Uppsala, Sweden) density gradient centrifugation following the manufacturerâ€™s protocol. PBMCs were stimulated using plate-bound anti-CD3 (2Â Âµg/mL, clone OKT3) and anti-CD28 (2Â Âµg/mL, clone CD28.2) antibodies (BioLegend, San Diego, CA, USA) in the presence of 100 U/mL IL-2 (ProSpec, East Brunswick, NJ, USA). Cells were cultured in iMediam for T (GC Lymphotec, Tokyo, Japan) and diluted to 5â€‰Ã—â€‰10<sup>5</sup> cells/mL by adding fresh culture medium supplemented with 25 U/mL IL-2 on days 4, 7, and 10. On day 14, T cells were used for co-culture experiments. All protocols and experiments involving primary PBMCs were approved by the Institutional Review Board of Showa University. Informed consent was obtained from all the volunteers.</p>
<p id="Par17">Mouse T cells were isolated from the splenocytes of female BALB/c mice (6â€“8Â weeks old) through positive selection using CD90.2 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), following the manufacturerâ€™s protocol. Isolated cells were stimulated with plate-bound anti-CD3 Îµ (2Â Âµg/mL, clone 145-2C11) and anti-CD28 (1Â Âµg/mL, clone 37.51) antibodies (BioLegend) in the presence of 100 U/ml IL-2 (ProSpec). For mouse T-cell activation, cells were cultured in RPMI-1640 medium supplemented with 10% FBS and 1â€‰Ã—â€‰penicillin/streptomycin solution. The cells were diluted to 1â€‰Ã—â€‰10<sup>6</sup> cells/mL by adding fresh culture medium supplemented with 20 U/mL IL-2 on day 3. On day 4, T cells were used for the co-culture experiments.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Co-culture experiments</h3>
<p id="Par18">Cancer cells (T3M-1, 5â€‰Ã—â€‰10<sup>4</sup> cells and CT-26, 2.5â€‰Ã—â€‰10<sup>4</sup> cells) were seeded at least 2Â h before T-cell addition, and activated T cells (human T, 5â€‰Ã—â€‰10<sup>5</sup> cells and mouse T, 2.5â€‰Ã—â€‰10<sup>5</sup> cells) were co-cultured in 6-well plates with the specified T-cell medium in a total volume of 2Â mL. Inosine (Fujifilm, Osaka, Japan) was prepared in PBS at a 100-fold concentration, and 1/100th volume was added to the culture medium. The adenosine A2A receptor antagonist <a href="https://www.ncbi.nlm.nih.gov/protein/SCH58261" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH58261</a> (TCI Chemicals, Tokyo, Japan) was added to the culture medium 30Â min prior to the addition of T cells. The co-culture was maintained at 37Â Â°C in 5% CO<sub>2</sub> for 72Â h following the addition of inosine. The absolute numbers of T and cancer cells were determined through flow cytometry (FCM) using fluorescent counting beads (Flow-Count; Beckman Coulter, Brea, CA, USA). After collecting the floating cells, adherent cells were trypsinized and collected in the same tube containing a defined number of counting beads. Part of this suspension was stained with a fluorophore-conjugated anti-mouse CD3 antibody to determine the cancer-to-T-cell ratio. CD3â€‰+â€‰cells were defined as T cells and all others as cancer cells. Additionally, co-cultured mouse T cells were assessed for surface activation markers using FCM.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Mouse tumor model</h3>
<p id="Par19">BALB/c mice were purchased from CLEA Japan (Tokyo, Japan) and maintained at a constant temperature (23â€‰Â±â€‰1Â Â°C) with a 12Â h light/dark cycle under specific pathogen-free conditions. The experimental protocols were approved by the Institutional Animal Care and Use Committee of Showa University, and all experiments were conducted according to the relevant guidelines and regulations. Female mice (8â€“12Â weeks old) were subcutaneously injected with CT-26 (1â€‰Ã—â€‰10<sup>5</sup> cells in 50Â Î¼L Hanksâ€™ Balanced Salt Solution) in the right flank. Mice were intraperitoneally administered 1Â g/kg inosine or an equivalent volume of saline solution every alternate day, starting from day 5 following tumor inoculation until the end of the experiment. Additionally, they received intraperitoneal injection of anti-PD-1 (clone RMP1-14, BioXcell, Lebanon, NH), anti-CTLA-4 (clone 9D9, BioXcell, Lebanon, NH), or control IgG (rat IgG for anti-PD-1 and mouse IgG for anti-CTLA-4, both from FUJIFILM). Unless otherwise stated, the dose of these antibodies was 150Â Âµg per mouse, administered once a week from day 4. In the experiment investigating the effect of inosine on dual ICI, the dose of ICI was 100Â Âµg per mouse and treatment started on day 11. For depletion of CD8â€‰+â€‰T cells, 100Â Âµg anti-CD8 (clone 2.43, BioXcell) antibody was administered on days 4, 11, and 18. Tumor length and width were measured twice a week using calipers, and tumor volumes were calculated as a lengthâ€‰Ã—â€‰width<sup>2</sup>â€‰Ã—â€‰0.5. On day 28 following tumor inoculation, the mice were euthanized for sample collection. Mice were categorized into responder and non-responder groups based on the final tumor volume. Mice with tumor volumesâ€‰&lt;â€‰500Â mm<sup>3</sup> on the final day were classified as responders, while those withâ€‰â‰¥â€‰500Â mm<sup>3</sup> were classified as non-responders.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Immunohistochemistry (IHC)</h3>
<p id="Par20">Tumor-infiltrating lymphocytes (TILs) were assessed using immunostaining with an anti-CD3 [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Sections of formalin-fixed, paraffin-embedded tumor tissues were mounted on silane-coated glass slides. Following deparaffinization, the antigens were retrieved by autoclaving in citrate buffer (pH 6; AS ONE, Osaka, Japan). Endogenous peroxidase was inhibited using 0.3% hydrogen peroxide, and non-specific staining was prevented using a non-specific blocking reagent (DAKO, Tokyo, Japan). Sections were incubated with a primary antibody (anti-mouse CD3 Îµ chain rabbit monoclonal antibody, clone SP7, Abcam, Cambridge, UK), followed by a peroxidase-linked secondary antibody (EnVision, DAKO). Color was developed using the DAB Liquid System (DAKO). TILs were assessed in a blinded manner by counting CD3â€‰+â€‰cells in six high-power fields using 4â€“5 mice per group. Data were expressed as the number of CD3â€‰+â€‰cells/mm<sup>2</sup>.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Quantitative reverse transcription (RT)-PCR</h3>
<p id="Par21">Total RNA from tumor tissues was isolated using an RNAeasy mini kit with a QIAshredder (Qiagen, Hilden, Germany), followed by reverse transcription using a High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific), following the manufacturerâ€™s protocol. Multiplex qPCR assays were performed on QuantStudio3 using TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific). These assays used a FAM-labeled probe for the target gene and a VIC-labeled mouse actin beta (<em>Actb</em>) endogenous control (Thermo Fisher Scientific). Predesigned PrimeTime qPCR assays for <em>Foxp3</em> and <em>Infg</em> (assay ID Mm.PT.58.16779326 and Mm.PT.58.41769240, respectively) were purchased from Integral DNA Technologies (Coralville, IA, USA). Relative gene expression levels were calculated using the comparative Ct method and expressed as fold-change relative to the reference sample.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Flow cytometry (FCM)</h3>
<p id="Par22">Splenocytes and lymph node cells were isolated by grinding the spleen and draining lymph nodes (axillary and inguinal) in RPMI-1640 medium, respectively, followed by red blood cell lysis. TILs were isolated by cutting tumor tissues intoâ€‰&lt;â€‰1 mm<sup>3</sup> pieces and digesting in 4Â mL RPMI-1640 medium (without FBS) containing 0.02Â mg/mL DNase I and 0.1Â mg/mL Liberase (Roche, Mannheim, Germany) at 37Â Â°C for 1Â h with shaking. The reaction was neutralized by adding 5Â mL of RPMI-1640 medium supplemented with 10% FBS and 2Â mM ethylenediaminetetraacetic acid. The cell suspension was passed through a 100Â Î¼m cell strainer and resuspended in 2Â mL of RPMI-1640 medium supplemented with 10% FBS. The tumor-cell suspension was layered on top of the 2Â mL Ficoll-Paque PLUS and centrifuged at 400â€‰Ã—â€‰<em>g</em> for 20Â min at 20Â Â°C. The leukocyte layer was carefully transferred and resuspended in PBS with 2% FBS. Fc-mediated antibody binding was blocked using anti-CD16/32 (Tonbo Biosciences, San Diego, CA, USA) before reacting with antibodies against the target molecules. Antibodies used in this study for the analysis of mouse splenic T cells are listed in Tables <a href="#MOESM1" class="usa-link">S1</a>â€“S3. For live cell gating, BD Horizon Fixable Viable Stain 780 (FVS780; BD Biosciences, Franklin Lakes, NJ, USA) was used. A transcription factor buffer set (BD Biosciences) was used for intracellular staining. For IFNÎ³ staining, lymphocytes from tumor tissues were stimulated using 1Â Âµg/mL ionomycin and 50Â ng/mL phorbol 12-myristate 13-acetate with GolgiStop (BD Life Sciences) for 4Â h at 37Â Â°C. Cells were harvested, stained for cell surface antigen, and then fixed and permeabilized using a BD Cytofix/Cytoperm Plus Fixation/Permeabilization Kit with BD GolgiStop (BD Life Sciences) according to the manufacturerâ€™s instructions. Cells were then stained for intracellular IFNÎ³. FCM was performed on a BD LSRFortessa or BD FACSLyric, and the data were analyzed using FlowJo v10.10.0 software (BD Life Sciences).</p></section><section id="Sec10"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par23">Data from three or more groups were analyzed using analysis of variance (ANOVA) with Dunnettâ€™s multiple comparison test. Tumor growth curves from the mouse subcutaneous tumor model were compared using two-way ANOVA with Holmâ€“Sidakâ€™s multiple comparison test. Data from two groups were analyzed using an unpaired two-tailed Studentâ€™s t-test. For the analysis of mouse tumor models in which tumor sizes vary greatly within a group, areas under tumor growth curve were compared using Kruskalâ€“Wallis test with Dunnâ€™s multiple comparison test. Statistical analyses were performed using GraphPad Prism version 10 for MacOS (GraphPad Software, Boston, MA, USA; <a href="http://www.graphpad.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.graphpad.com</a>). Statistical significance was set at <em>P</em>â€‰&lt;â€‰0.05. To examine the additive effect of inosine on dual immune checkpoint blockade, tumor growth data were analyzed using a linear mixed-effects model (LMM) in R (Version 1.4.1106) with the <em>lme4</em>, <em>lmerTest</em>, and t<em>idyverse</em> packages. The model included fixed effects for time (Days), treatment group (inosine vs. control), and their interaction, with mouse identity specified as a random intercept: TumorVolumeâ€‰~â€‰Days * Groupâ€‰+â€‰(1 | Mouse). The significance of fixed effects was assessed using Satterthwaiteâ€™s approximation for degrees of freedom.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Study approval</h3>
<p id="Par24">All protocols and experiments involving primary PBMCs were approved by the Institutional Review Board of Showa University. Informed consent was obtained from all the volunteers. For animal studies, the experimental protocols were approved by the Institutional Animal Care and Use Committee of Showa University, and all experiments were conducted according to theÂ ARRIVE (Animal Research: Reporting of In Vivo Experiments)Â guidelines.</p></section></section><section id="Sec12"><h2 class="pmc_sec_title">Results</h2>
<p id="Par25">Initially, we assessed the effects of inosine, a gut bacterial metabolite, on the survival of cancer and T cells in a co-culture setting (Fig.Â <a href="#Fig1" class="usa-link">1</a>a). Under co-culture conditions, inosine did not inhibit human T-cell survival. In contrast, the proliferation of the human squamous cell carcinoma cell line T3M-1 was inhibited in a concentration-dependent manner (â‰¥â€‰1Â mM). Additionally, the effects of inosine were assessed in a cell monoculture system. Inosine inhibited the proliferation of T3M-1 cells only at a concentration of 10Â mM (Fig. <a href="#MOESM1" class="usa-link">S1</a>a). Similar to that in co-culture conditions, inosine exhibited no inhibitory effect on the proliferation of activated T cells, even at 10Â mM (Fig. <a href="#MOESM1" class="usa-link">S1</a>b). These results indicated that inosine selectively inhibited the proliferation of cancer cells over T cells. Moreover, we assessed the effects of inosine on mouse T cells and CT-26 colon cancer cells under co-culture conditions (Fig.Â <a href="#Fig1" class="usa-link">1</a>b). Inosine selectively suppressed the growth of CT-26 cells at a concentration of 10Â mM, reproducing the results obtained in human cells. Furthermore, we assessed whether inosine exerted any modulatory effects on T cells under in vitro co-culture conditions (Fig.Â <a href="#Fig1" class="usa-link">1</a>c). The expression levels of T-cell activation markers, such as inducible T-cell costimulator (ICOS) and cluster of differentiation 95 (CD95), in CD8â€‰+â€‰T cells and CD95 in CD4â€‰+â€‰T cells increased in an inosine concentration-dependent manner (Fig.Â <a href="#Fig1" class="usa-link">1</a>c, <a href="#MOESM1" class="usa-link">S2</a>). These results indicate that inosine exhibited stimulatory effects. The inosine-induced changes observed in the murine co-culture system were not reversed in the presence of the adenosine A2A receptor antagonist <a href="https://www.ncbi.nlm.nih.gov/protein/SCH58261" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH58261</a> at 1Â Î¼M (Fig. <a href="#MOESM1" class="usa-link">S3</a>). Assuming an ECâ‚…â‚€ of 0.3Â mM for inosine at the A2A receptor [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>] and a Kd of 1Â nM for <a href="https://www.ncbi.nlm.nih.gov/protein/SCH58261" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH58261</a> [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>], the predicted receptor activation at 10Â mM inosine in the presence of 1Â ÂµM <a href="https://www.ncbi.nlm.nih.gov/protein/SCH58261" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH58261</a> is approximately 3% based on a competitive binding model. Therefore, the inosine-induced effects observed in our system are unlikely to be mediated through A2A receptor activation.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig.Â 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364772_262_2025_4111_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/12364772/2dd452706029/262_2025_4111_Fig1_HTML.jpg" loading="lazy" id="MO1" height="1070" width="750" alt="Fig.Â 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Selective inhibition of cancer cells by inosine. <strong>a</strong> Effect inosine on the survival of T3M-1 Clone2 oral cancer cells (open circles) and human T cells (black circles) in co-culture. Data are represented as fold-changes relative to the control (treated with phosphate-buffered saline, PBS). <strong>b</strong> Effect of inosine on the survival of CT-26 colon cancer cells (open circles) and mouse T cells (black circles) in co-culture. Data are represented as fold-changes relative to the PBS control. <strong>c</strong> Expression of surface activation markers in CD8â€‰+â€‰(upper panels) and CD4â€‰+â€‰(lower panels) T cells in co-culture with CT-26 cells in various inosine concentrations. Data are presented as means with SEM from three independent experiments. *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, and ****<em>P</em>â€‰&lt;â€‰0.0001 vs. PBS control</p></figcaption></figure><p id="Par26">Subsequently, to assess whether the results obtained in vitro can be reproduced in a mouse tumor model, mouse colon cancer cells (CT-26) were subcutaneously implanted in the flanks of BALB/c mice and treated with inosine. Compared with that of the control group, the inosine-treated group demonstrated reduced growth of subcutaneous tumor tissue over time (Fig.Â <a href="#Fig2" class="usa-link">2</a>a), and the tumor volume on day 28 was significantly smaller in the inosine-treated group than that in the control group (Fig.Â <a href="#Fig2" class="usa-link">2</a>b). All mice in the control group exhibited tumor progression. Tumor growth was also observed in all mice in the inosine group, but of a lesser degree than that in the control group (Fig.Â <a href="#Fig2" class="usa-link">2</a>c). None of the individuals exhibited tumor regression after inosine treatment (Fig.Â <a href="#Fig2" class="usa-link">2</a>d). To determine whether the antitumor effect of inosine is mediated by the immune system, we depleted CD8â€‰+â€‰T cells and assessed tumor growth. Combined treatment with anti-CD8 and inosine exacerbated the tumor growth compared to that of mice treated only with inosine (Fig. <a href="#MOESM1" class="usa-link">S4</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h3 class="obj_head">Fig.Â 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364772_262_2025_4111_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/12364772/f3a05d8480a6/262_2025_4111_Fig2_HTML.jpg" loading="lazy" id="MO2" height="432" width="708" alt="Fig.Â 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Antitumor effects of inosine in a mouse CT-26 subcutaneous model. <strong>a</strong> Tumor growth curve of mice treated with PBSâ€‰+â€‰IgG (black) or inosineâ€‰+â€‰IgG (orange). Data are expressed as means with SEM from 9 to 11 mice per group. <strong>b</strong> Tumor volume at the end of the experiment. Data are expressed as means with SEM. <strong>c</strong> Tumor growth curves of individual mice. <strong>d</strong> Pictures of resected tumors at the end of the experiment. *<em>P</em>â€‰&lt;â€‰0.05 by Studentâ€™s t-test</p></figcaption></figure><p id="Par27">Subsequently, we aimed to elucidate the mechanism by which inosine inhibits tumor growth in vivo. TILs were quantified by immunostaining tumor tissues with anti-CD3. Compared with that of the control group, more T cells infiltrated the tumors in the inosine-treated group (Fig.Â <a href="#Fig3" class="usa-link">3</a>a). Additionally, <em>Ifng</em> gene expression in tumor tissues was increased in the inosine-treated group compared to that in the control group (Fig.Â <a href="#Fig3" class="usa-link">3</a>b). Moreover, the percentages of CD4â€‰+â€‰and CD8â€‰+â€‰T cells in the spleen increased in the inosine-treated group (Fig.Â <a href="#Fig3" class="usa-link">3</a>c). However, the proportions of CD4â€‰+â€‰and CD8â€‰+â€‰T cells in tumor tissues were not altered by inosine treatment (Fig. S5a). Furthermore, flow cytometric analysis showed no change in IFNÎ³ expression levels in tumor tissues (Fig. S5b). These results indicate that the antitumor effects of inosine are mediated through antitumor immunity.</p>
<figure class="fig xbox font-sm" id="Fig3"><h3 class="obj_head">Fig.Â 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364772_262_2025_4111_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/12364772/94701e5d2eac/262_2025_4111_Fig3_HTML.jpg" loading="lazy" id="MO3" height="803" width="709" alt="Fig.Â 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immunostimulatory effects of inosine. <strong>a</strong> Immunostaining of resected tumor tissue with anti-CD3. Left: representative micrographs. Scale barâ€‰=â€‰200Â Âµm. Right: number of CD3â€‰+â€‰cells/mm<sup>2</sup>. Data are expressed as means with SEM from four mice per group. <strong>b</strong> Relative gene expression of <em>IFNG</em> in tumor tissues from control and inosine-treated mice quantified through RT-qPCR analysis. <strong>c</strong> Percentage of CD4â€‰+â€‰(left) and CD8â€‰+â€‰(right) T cells in total splenocytes from tumor model mice at the end of the experiment. Data are expressed as means with SEM from 9 to 11 mice. *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, and ***<em>P</em>â€‰&lt;â€‰0.001 by Studentâ€™s t-test</p></figcaption></figure><p id="Par28">TILs are predictive biomarkers for the efficacy of ICIs. Therefore, we hypothesized that inosine may potentiate the effects of ICIs by increasing the number of TILs. To test this, we treated a mouse subcutaneous tumor model with an anti-PD-1 alone or in combination with inosine, and compared the alterations in tumor growth over time (Fig.Â <a href="#Fig4" class="usa-link">4</a>a, b). In the group treated with the anti-PD-1 alone, 9 out of 10 mice responded to the treatment (Fig.Â <a href="#Fig4" class="usa-link">4</a>d, e). In contrast, only 7 out of 11 animals responded to the combined treatment (Fig.Â <a href="#Fig4" class="usa-link">4</a>d, e). Notably, the tumor size of non-responsive individuals was larger in the inosine combination group than that in the anti-PD-1 monotherapy group (Fig.Â <a href="#Fig4" class="usa-link">4</a>b). Furthermore, comparison of the area under the tumor growth curve showed that tumor burden tended to increase with inosine addition, although the difference was not statistically significant (Fig.Â <a href="#Fig4" class="usa-link">4</a>c). These results indicate that contrary to expectations, inosine suppressed the antitumor effects of anti-PD-1.</p>
<figure class="fig xbox font-sm" id="Fig4"><h3 class="obj_head">Fig.Â 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364772_262_2025_4111_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/12364772/45fd87371747/262_2025_4111_Fig4_HTML.jpg" loading="lazy" id="MO4" height="500" width="708" alt="Fig.Â 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Inosine suppresses the antitumor effects of anti-programmed cell death protein 1 (anti-PD-1) antibody in a mouse CT-26 subcutaneous model. <strong>a</strong> Tumor growth curve of mice treated with PBSâ€‰+â€‰IgG (black), PBSâ€‰+â€‰anti-PD-1 (red) and inosineâ€‰+â€‰anti-PD-1 (blue). Data are expressed as means with SEM from 9 to 11 mice per group. <strong>b</strong> Tumor growth curves of individual mice. <strong>c</strong> Area under the tumor growth curve. Each dot represents an individual value. <strong>d</strong> Pictures of resected tumors at the end of the experiment. Blanks indicate the disappearance of the tumor. <strong>e</strong> Number of responders and non-responders</p></figcaption></figure><p id="Par29">Subsequently, we assessed why inosine suppressed the antitumor effects of anti-PD-1. Anti-CD3 immunostaining of tumor tissues exhibited no significant reduction in TILs in the inosine combination group compared to that in the anti-PD-1 monotherapy group (Fig.Â <a href="#Fig5" class="usa-link">5</a>a). Quantitative PCR of tumor tissues demonstrated that the expression of <em>Foxp3</em>, a master transcription factor for Tregs, was higher in the inosine combination group than that in the anti-PD-1 monotherapy group (Fig.Â <a href="#Fig5" class="usa-link">5</a>b). FCM analysis of splenocytes demonstrated that the percentage of Tregs was higher in the inosine combination group than that in the anti-PD-1 monotherapy group (Fig.Â <a href="#Fig5" class="usa-link">5</a>c, <a href="#MOESM1" class="usa-link">S7</a>). These results indicate that the combination of an anti-PD-1 and inosine increased the number of Tregs. Additionally, we evaluated CTLA-4 expression in tumor tissues, draining lymph nodes, and spleen. CTLA-4 expression in splenic CD8â€‰+â€‰T cells increased in the inosine combination group compared to that in the anti-PD-1 monotherapy group (Fig.Â <a href="#Fig5" class="usa-link">5</a>d, <a href="#MOESM1" class="usa-link">S8</a>). In tumor-draining lymph nodes and tumor tissues, CTLA-4 expression was unaffected by the addition of inosine (Fig. <a href="#MOESM1" class="usa-link">S8</a>a, b). These findings imply that the addition of inosine to anti-PD-1 treatment may contribute to attenuated antitumor effects, potentially through increased Tregs and elevated CTLA-4 expression in splenic T cells. Furthermore, inosine stimulation increased CTLA-4 expression in in vitro cultured CD8âº T cells, mirroring the results observed in splenic T cells in vivo (Fig. <a href="#MOESM1" class="usa-link">S7</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h3 class="obj_head">Fig.Â 5.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364772_262_2025_4111_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/12364772/8d20467e900a/262_2025_4111_Fig5_HTML.jpg" loading="lazy" id="MO5" height="709" width="709" alt="Fig.Â 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Upregulation of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) expression by the combination of inosine and anti-programmed cell death protein 1 (anti-PD-1) antibody. <strong>a</strong> Immunostaining of resected tumor tissue with anti-CD3. Left: representative micrographs. Scale barâ€‰=â€‰200Â Âµm. Right: number of CD3â€‰+â€‰cells/mm<sup>2</sup>. Data are expressed as means with SEM from four mice per group. ns, not significant. <strong>b</strong> Relative gene expression of <em>FoxP3</em> in tumor tissues from mice treated with PBSâ€‰+â€‰anti-PD-1 and inosineâ€‰+â€‰anti-PD-1 quantified through RT-qPCR analysis. Data are expressed as means with SEM from 4 to 5 mice. Numbers indicate p values. <strong>c</strong> Percentage of CD4â€‰+â€‰FoxP3â€‰+â€‰T cells in spleen and CD3â€‰+â€‰cells from tumor model mice at the end of the experiment. Data are expressed as means with SEM from 9 to 11 mice. Numbers indicate p values. <strong>d</strong> Expression of CTLA-4 in CD4â€‰+â€‰(left) and CD8â€‰+â€‰(right) splenic T cells. Data are expressed as means with SEM from 9 to 11 mice. MFI, mean fluorescence intensity. <strong>e</strong> Expression of CTLA-4 in CD4â€‰+â€‰T (left), CD8â€‰+â€‰T (middle), and Treg (right) cells in lymph nodes. Numbers indicate p values. *<em>P</em>â€‰&lt;â€‰0.05 by Studentâ€™s t-test</p></figcaption></figure><p id="Par30">As the spleen is a major site of peripheral T-cell activation and regulation, we hypothesized that increased CTLA-4 expression in this compartment might contribute to systemic immune suppression and interfere with anti-PD-1 efficacy. Therefore, we tested whether CTLA-4 blockade could overcome this suppressive effect and restore antitumor immunity. Tumor growth was suppressed in the inosine and anti-PD-1 combination group compared to that in the untreated group (Fig.Â <a href="#Fig6" class="usa-link">6</a>a). Moreover, 5 out of 10 individuals responded to the treatment (Fig.Â <a href="#Fig6" class="usa-link">6</a>b, c). In contrast, in the group receiving anti-CTLA-4 in addition to the combination of inosine and anti-PD-1, tumor growth was further suppressed compared to group receiving combined inosine and anti-PD-1 (Fig.Â <a href="#Fig6" class="usa-link">6</a>a). Tumor regression was observed in all individuals (Fig.Â <a href="#Fig6" class="usa-link">6</a>b, c). These results indicate that the anti-CTLA-4 ameliorated the reduced antitumor effects caused by the combination of inosine and anti-PD-1. Finally, we investigated whether inosine enhances the effect of dual immune checkpoint blockade. To appropriately evaluate the potential additive effect of inosine, we reduced the dose of anti-PD-1 and anti-CTLA-4 antibodies from the standard 150Â Âµg to 100Â Âµg per mouse, since the full dose elicited strong antitumor effects on its own. Compared to those in the reduced-dose dual ICI group, mice receiving additional inosine tended to show less tumor growth (Fig.Â <a href="#Fig6" class="usa-link">6</a>f, g). LMM revealed a significant interaction between treatment group and time (Daysâ€‰Ã—â€‰Group: coefficientâ€‰=â€‰â€‰âˆ’â€‰22.49, <em>p</em>â€‰=â€‰0.012), indicating that inosine significantly attenuated tumor growth rate over time. These results suggest that inosine may enhance the antitumor effect of dual ICI therapy under the conditions of partial immune activation.</p>
<figure class="fig xbox font-sm" id="Fig6"><h3 class="obj_head">Fig.Â 6.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364772_262_2025_4111_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/12364772/e7b68ecdde9d/262_2025_4111_Fig6_HTML.jpg" loading="lazy" id="MO6" height="1170" width="722" alt="Fig.Â 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody overcomes the inhibitory effects of inosine in combination with anti-programmed cell death protein 1 (PD-1) antibody in a mouse CT-26 subcutaneous tumor model. <strong>a</strong> Tumor growth curve of mice treated with PBS (black), inosineâ€‰+â€‰anti-PD-1â€‰+â€‰IgG (blue), or inosineâ€‰+â€‰anti-PD-1â€‰+â€‰anti-CTLA-4 (magenta). The inosine-treated groups received intraperitoneal injections (150Â Âµg per mouse) of anti-PD-1 and mouse IgG or anti-CTLA-4 on days 4, 11, 18, and 25. Data are expressed as means with SEM from 10 mice per group. <strong>b</strong> Area under the tumor growth curve. Each dot represents an individual value. Numbers indicate p values from Dunnâ€™s multiple comparison test. <strong>c</strong> Tumor growth curves of individual mice. <strong>d</strong> Number of responders and non-responders. <strong>e</strong> Pictures of resected tumors at the end of the experiment. Blanks indicate the disappearance of the tumor. <strong>f</strong> Tumor growth curve of mice treated with anti-PD-1â€‰+â€‰anti-CTLA-4 (green) or inosineâ€‰+â€‰anti-PD-1â€‰+â€‰anti-CTLA-4 (magenta). Data points represent mean tumor volumesâ€‰Â±â€‰SEM at each time point for each treatment group (nâ€‰=â€‰8â€“9). Solid lines indicate group-wise means of observed values, and dashed lines represent predicted tumor growth curves estimated by a linear mixed-effects model (LMM), incorporating fixed effects of treatment, time (Days), and their interaction. The LMM revealed a significant interaction between treatment and time (Daysâ€‰Ã—â€‰Group: coefficientâ€‰=â€‰â€‰âˆ’â€‰22.49,Â <em>p</em>â€‰=â€‰0.012), indicating that inosine treatment significantly attenuated tumor growth over time. <strong>g</strong> Tumor growth curves of individual mice</p></figcaption></figure></section><section id="Sec13"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par31">This study demonstrated the antitumor effects of inosine in both in vitro co-culture systems and in vivo subcutaneous tumor models. In monoculture systems, inosine directly inhibited tumor-cell proliferation, indicating a cytostatic or cytotoxic effect on cancer cells. Interestingly, a more pronounced inhibitory effect was observed in T-cellâ€“cancer cell co-cultures, suggesting that inosine also enhances T-cell-mediated antitumor responses. In support of this, inosine increased the expression of multiple T-cell activation markers, such as ICOS and CD95, particularly in CD8â€‰+â€‰T cells. Although inosine acts as an adenosine A2A receptor (A2AR) agonist, the T-cell-stimulatory effects observed in vitro were not reversed by co-treatment with the A2AR antagonist <a href="https://www.ncbi.nlm.nih.gov/protein/SCH58261" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH58261</a>, even at a concentration sufficient to block receptor signaling. This suggests that the immunostimulatory effects of inosine under these conditions are likely A2AR-independent. Instead, recent studies have proposed that inosine may influence T-cell function through receptor-independent mechanisms such as metabolic reprogramming [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Inosine serves as an alternative carbon source that fuels oxidative phosphorylation and supports effector T-cell survival and function under nutrient-limited or hypoxic conditions [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Thus, the enhanced T-cell activation observed in our co-culture model may, at least in part, result from inosine-mediated metabolic support rather than canonical A2AR signaling. Importantly, the 10Â mM concentration of inosine used in our in vitro experiments is physiologically relevant, as Mager et al. reported similar circulating levels in mice [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Moreover, inosine affects T-cell metabolism at millimolar concentrations [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>], supporting a receptor-independent metabolic mechanism in our system.</p>
<p id="Par32">The suppression of tumor growth in the mouse subcutaneous tumor model appears to be immune-mediated, as it was accompanied by increased Ifng expression in the TME, enhanced infiltration by TILs, and elevated proportions of splenic CD4â€‰+â€‰and CD8â€‰+â€‰T cells. The concentration-dependent increase in T-cell activation markers observed in vitro further supports this interpretation. Moreover, depletion of CD8â€‰+â€‰T cells abrogated the antitumor effect of inosine, demonstrating that these cells play a critical role in mediating its efficacy. The antitumor effect of inosine has been reported by Zhang et al., who observed tumor suppression in B16-F0 and B16-GM-CSF models, but not in the 4T1 breast cancer model [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Similarly, another study using B16-F10 cells showed no in vivo efficacy [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>], suggesting that inosineâ€™s effect depends on tumor type. Our study extends these findings by demonstrating that inosine alone suppresses tumor growth in a CT26 colon cancer model through a CD8â€‰+â€‰T-cell-dependent mechanism. This highlights the broader potential of inosine as an immune-modulating agent and emphasizes the importance of tumor context in determining therapeutic response.</p>
<p id="Par33">Another major finding of this study was the inhibitory effect of inosine on the antitumor effect of anti-PD-1 therapy. Because the antitumor effects of inosine were accompanied by T-cell activation and increased TILs, a synergistic effect of inosine and ICI was anticipated. Contrary to our expectations, the tumors were larger when inosine was combined with anti-PD-1 therapy than when anti-PD-1 was used alone. Several studies have indicated the synergistic effects of a combination of inosine and ICIs; however, these studies used various ICIs. No previous study has assessed the combined effect of anti-PD-1 therapy and inosine in a mouse model; the mechanistically closest setting was reported by Wang et al., who combined anti-PD-L1 treatment and inosine [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. In their study, using a B16-F10 subcutaneous tumor model, inosine combined with anti-PD-L1 therapy suppressed tumor growth and prolonged individual survival, in contrast to our results. These discrepancies may stem from the use of different tumor cells and distinct mechanisms of PD-1 and PD-L1 inhibition. Additionally, a recent phase 2 clinical study by Zhao et al. reported that inosine enhanced the efficacy of PD-1/PD-L1 inhibitors in patients with advanced solid tumors [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The study demonstrated that the addition of inosine prolonged progression-free survival and improved objective response rates. However, the results varied across different tumor types and treatment regimens. These findings suggest that the effects of inosine in combination with ICIs may be context-dependent and influenced by the tumor type, immune microenvironment, and specific checkpoint inhibitors used.</p>
<p id="Par34">Based on the increased splenic Tregs and FoxP3 expression in tumor tissue, as well as the elevated CTLA-4 expression in splenic CD8â€‰+â€‰T cells, we hypothesized that CTLA-4-mediated immune regulation might contribute to the reduced efficacy of anti-PD-1 when combined with inosine. Indeed, the addition of anti-CTLA-4 reversed this attenuation and led to tumor regression in all treated animals, consistent with findings reported by Zhang et al. [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>], although different tumor models were used. While these results suggest a role for CTLA-4-associated suppression, the underlying mechanism remains unclear. Notably, the increase in CTLA-4 expression was observed only in splenic T cells, with no changes in tumor or draining lymph node compartments, making it difficult to determine whether CTLA-4 directly mediates the suppressive effect of inosine. Previous studies have shown that CTLA-4 expression can be modulated by purinergic signaling, but whether this applies to inosine in our model is unclear. Together, our findings imply that inosine may activate compensatory regulatory pathways that limit PD-1-targeted therapy, but further investigation is required to clarify the molecular and cellular basis of this effect.</p>
<p id="Par35">Our results suggest that inosine may enhance the efficacy of dual immune checkpoint blockade with anti-PD-1 and anti-CTLA-4 antibodies. Given that <em>Bifidobacterium pseudolongum</em>, a known inosine-producing species, is associated with improved responses to ICIs [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>], both microbial composition and fecal inosine levels may serve as useful biomarkers to guide treatment strategies. Notably, microbial metabolites exert diverse effects on the immune systemâ€”short-chain fatty acids, for example, potentiate the efficacy of anti-PD-1 therapy while limiting that of anti-CTLA-4 [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>], in contrast to the actions of inosine observed in our study. These findings underscore that bacterial metabolites act through distinct and sometimes opposing mechanisms, and that their compatibility with specific ICIs may vary. Further studies are needed to elucidate the precise immunological roles of these metabolites and to determine how they might be leveragedâ€”either alone or in combination with ICIsâ€”to optimize cancer immunotherapy.</p></section><section id="Sec14"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12364772/bin/262_2025_4111_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (PDF 780 KB)</a><sup> (779.6KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors would like to thank the members of the Immuno-Oncology research group at Pharmacological Research Center, Showa Medical University, for their helpful discussions. We also acknowledge the Showa Medical University Clinical Medicine Joint Research Laboratory for the use of the BD FACSLyric. English language editing was provided by Editage (<a href="http://www.editage.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.editage.com</a>).</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ADORA2A</dt>
<dd><p id="Par2">Adenosine 2A receptor</p></dd>
<dt>FBS</dt>
<dd><p id="Par3">Fetal bovine serum</p></dd>
<dt>FCM</dt>
<dd><p id="Par4">Flow cytometry</p></dd>
<dt>ICI</dt>
<dd><p id="Par5">Immune checkpoint inhibitor</p></dd>
<dt>IFN-Î³</dt>
<dd><p id="Par6">Interferon gamma</p></dd>
<dt>PBMC</dt>
<dd><p id="Par7">Peripheral blood mononuclear cell</p></dd>
<dt>RT-PCR</dt>
<dd><p id="Par8">Reverse transcription polymerase chain reaction</p></dd>
<dt>TCGA</dt>
<dd><p id="Par9">The cancer genome atlas</p></dd>
<dt>TME</dt>
<dd><p id="Par10">Tumor microenvironment</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>AK, MH, and KY conceived and designed the study. YN, MM, EF, AS (Akiko Sasaki), YB, HT, JI, KT, RN, AS (Aya Sasaki), YM, YY, MS, and TT (Toshiaki Tsurui) performed the experiments. YN, AK, MH, YH, HA, TI, RS, RO, YK (Yutaro Kubota), and AH acquired and analyzed data. YN, AK, and KY wrote the manuscript, which was edited by TS, MT, SW, SK (Shinichi Kobayashi), TT (Takuya Tsunoda), SK (Sei Kobayashi), HK, TS, TO (Tatsunori Oguchi) and YK (Yujij Kiuchi). All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by Grant-in-Aid for Scientific Research (C) 22K09675.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets generated during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Conflict of interests</h3>
<p id="Par36">The authors have no relevant financial or non-financial interests to disclose.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Ethical approval</h3>
<p id="Par37">All protocols and experiments involving primary peripheral blood mononuclear cells were approved by the Institutional Review Board of Showa University. Informed consent was obtained from all blood donors. The animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Showa University, and all experiments were conducted according to theÂ relevant ARRIVEÂ guidelines.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bagchi S, Yuan R, Engleman EG (2021) Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol 16:223â€“249. 10.1146/annurev-pathol-042020-042741
</cite> [<a href="https://doi.org/10.1146/annurev-pathol-042020-042741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33197221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bagchi%20S,%20Yuan%20R,%20Engleman%20EG%20(2021)%20Immune%20checkpoint%20inhibitors%20for%20the%20treatment%20of%20cancer:%20clinical%20impact%20and%20mechanisms%20of%20response%20and%20resistance.%20Annu%20Rev%20Pathol%2016:223%E2%80%93249.%2010.1146/annurev-pathol-042020-042741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Binnewies M, Roberts EW, Kersten K et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541â€“550. 10.1038/s41591-018-0014-x
</cite> [<a href="https://doi.org/10.1038/s41591-018-0014-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5998822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29686425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Binnewies%20M,%20Roberts%20EW,%20Kersten%20K%20et%20al%20(2018)%20Understanding%20the%20tumor%20immune%20microenvironment%20(TIME)%20for%20effective%20therapy.%20Nat%20Med%2024(5):541%E2%80%93550.%2010.1038/s41591-018-0014-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Sadeghi Rad H, Monkman J, Warkiani ME et al (2021) Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev 41(3):1474â€“1498. 10.1002/med.21765
</cite> [<a href="https://doi.org/10.1002/med.21765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8247330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33277742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sadeghi%20Rad%20H,%20Monkman%20J,%20Warkiani%20ME%20et%20al%20(2021)%20Understanding%20the%20tumor%20microenvironment%20for%20effective%20immunotherapy.%20Med%20Res%20Rev%2041(3):1474%E2%80%931498.%2010.1002/med.21765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30(6):492â€“506. 10.1038/s41422-020-0332-7
</cite> [<a href="https://doi.org/10.1038/s41422-020-0332-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7264227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32433595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20D,%20Liwinski%20T,%20Elinav%20E%20(2020)%20Interaction%20between%20microbiota%20and%20immunity%20in%20health%20and%20disease.%20Cell%20Res%2030(6):492%E2%80%93506.%2010.1038/s41422-020-0332-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Gunjur A, Manrique-RincÃ³n AJ, Klein O et al (2022) â€œKnow thyselfâ€ â€” host factors influencing cancer response to immune checkpoint inhibitors. J Pathol 257(4):513â€“525. 10.1002/path.5907
</cite> [<a href="https://doi.org/10.1002/path.5907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9320825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35394069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gunjur%20A,%20Manrique-Rinc%C3%B3n%20AJ,%20Klein%20O%20et%20al%20(2022)%20%E2%80%9CKnow%20thyself%E2%80%9D%20%E2%80%94%20host%20factors%20influencing%20cancer%20response%20to%20immune%20checkpoint%20inhibitors.%20J%20Pathol%20257(4):513%E2%80%93525.%2010.1002/path.5907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>VÃ©tizou M, Pitt JM, DaillÃ¨re R et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079â€“1084. 10.1126/science.aad1329
</cite> [<a href="https://doi.org/10.1126/science.aad1329" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4721659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26541610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?V%C3%A9tizou%20M,%20Pitt%20JM,%20Daill%C3%A8re%20R%20et%20al%20(2015)%20Anticancer%20immunotherapy%20by%20CTLA-4%20blockade%20relies%20on%20the%20gut%20microbiota.%20Science%20350(6264):1079%E2%80%931084.%2010.1126/science.aad1329" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Sivan A, Corrales L, Hubert N et al (2015) Commensal <em>Bifidobacterium</em> promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350(6264):1084â€“1089. 10.1126/science.aac4255
</cite> [<a href="https://doi.org/10.1126/science.aac4255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4873287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26541606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sivan%20A,%20Corrales%20L,%20Hubert%20N%20et%20al%20(2015)%20Commensal%20Bifidobacterium%20promotes%20antitumor%20immunity%20and%20facilitates%20anti-PD-L1%20efficacy.%20Science%20350(6264):1084%E2%80%931089.%2010.1126/science.aac4255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Gopalakrishnan V, Spencer CN, Nezi L et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97â€“103. 10.1126/science.aan4236
</cite> [<a href="https://doi.org/10.1126/science.aan4236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5827966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29097493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gopalakrishnan%20V,%20Spencer%20CN,%20Nezi%20L%20et%20al%20(2018)%20Gut%20microbiome%20modulates%20response%20to%20anti-PD-1%20immunotherapy%20in%20melanoma%20patients.%20Science%20359(6371):97%E2%80%93103.%2010.1126/science.aan4236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Tanoue T, Morita S, Plichta DR et al (2019) A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565(7741):600â€“605. 10.1038/s41586-019-0878-z
</cite> [<a href="https://doi.org/10.1038/s41586-019-0878-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30675064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tanoue%20T,%20Morita%20S,%20Plichta%20DR%20et%20al%20(2019)%20A%20defined%20commensal%20consortium%20elicits%20CD8%20T%20cells%20and%20anti-cancer%20immunity.%20Nature%20565(7741):600%E2%80%93605.%2010.1038/s41586-019-0878-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Wang Y, Ma R, Liu F, Lee SA, Zhang L (2018) Modulation of gut microbiota: a novel paradigm of enhancing the efficacy of programmed death-1 and programmed death ligand-1 blockade therapy. Front Immunol 9:374. 10.3389/fimmu.2018.00374
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.00374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5845387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29556232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Ma%20R,%20Liu%20F,%20Lee%20SA,%20Zhang%20L%20(2018)%20Modulation%20of%20gut%20microbiota:%20a%20novel%20paradigm%20of%20enhancing%20the%20efficacy%20of%20programmed%20death-1%20and%20programmed%20death%20ligand-1%20blockade%20therapy.%20Front%20Immunol%209:374.%2010.3389/fimmu.2018.00374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Luu M, SchÃ¼tz B, Lauth M, Visekruna A (2023) The impact of gut microbiota-derived metabolites on the tumor immune microenvironment. Cancers (Basel) 15(5):1588. 10.3390/cancers15051588
</cite> [<a href="https://doi.org/10.3390/cancers15051588" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10001145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36900377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luu%20M,%20Sch%C3%BCtz%20B,%20Lauth%20M,%20Visekruna%20A%20(2023)%20The%20impact%20of%20gut%20microbiota-derived%20metabolites%20on%20the%20tumor%20immune%20microenvironment.%20Cancers%20(Basel)%2015(5):1588.%2010.3390/cancers15051588" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>De Vos WM, Tilg H, Van Hul M, Cani PD (2022) Gut microbiome and health: mechanistic insights. Gut 71(5):1020â€“1032. 10.1136/gutjnl-2021-326789
</cite> [<a href="https://doi.org/10.1136/gutjnl-2021-326789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8995832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35105664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Vos%20WM,%20Tilg%20H,%20Van%20Hul%20M,%20Cani%20PD%20(2022)%20Gut%20microbiome%20and%20health:%20mechanistic%20insights.%20Gut%2071(5):1020%E2%80%931032.%2010.1136/gutjnl-2021-326789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Murayama M, Hosonuma M, Kuramasu A et al (2024) Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody. Sci Rep 14(1):11325. 10.1038/s41598-024-59677-1
</cite> [<a href="https://doi.org/10.1038/s41598-024-59677-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11101641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38760458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murayama%20M,%20Hosonuma%20M,%20Kuramasu%20A%20et%20al%20(2024)%20Isobutyric%20acid%20enhances%20the%20anti-tumour%20effect%20of%20anti-PD-1%20antibody.%20Sci%20Rep%2014(1):11325.%2010.1038/s41598-024-59677-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Mager LF, Burkhard R, Pett N et al (2020) Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369(6510):1481â€“1489. 10.1126/science.abc3421
</cite> [<a href="https://doi.org/10.1126/science.abc3421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32792462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mager%20LF,%20Burkhard%20R,%20Pett%20N%20et%20al%20(2020)%20Microbiome-derived%20inosine%20modulates%20response%20to%20checkpoint%20inhibitor%20immunotherapy.%20Science%20369(6510):1481%E2%80%931489.%2010.1126/science.abc3421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Wang T, Gnanaprakasam JNR, Chen X et al (2020) Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nat Metab 2(7):635â€“647. 10.1038/s42255-020-0219-4
</cite> [<a href="https://doi.org/10.1038/s42255-020-0219-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7371628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32694789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20T,%20Gnanaprakasam%20JNR,%20Chen%20X%20et%20al%20(2020)%20Inosine%20is%20an%20alternative%20carbon%20source%20for%20CD8+-T-cell%20function%20under%20glucose%20restriction.%20Nat%20Metab%202(7):635%E2%80%93647.%2010.1038/s42255-020-0219-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhang L, Jiang L, Yu L et al (2022) Inhibition of UBA6 by inosine augments tumour immunogenicity and responses. Nat Commun 13(1):5413. 10.1038/s41467-022-33116-z
</cite> [<a href="https://doi.org/10.1038/s41467-022-33116-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9478149/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36109526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Jiang%20L,%20Yu%20L%20et%20al%20(2022)%20Inhibition%20of%20UBA6%20by%20inosine%20augments%20tumour%20immunogenicity%20and%20responses.%20Nat%20Commun%2013(1):5413.%2010.1038/s41467-022-33116-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Welihinda AA, Kaur M, Greene K, Zhai Y, Amento EP (2016) The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias. Cell Signal 28(6):552â€“560. 10.1016/j.cellsig.2016.02.010
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2016.02.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4826793/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26903141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Welihinda%20AA,%20Kaur%20M,%20Greene%20K,%20Zhai%20Y,%20Amento%20EP%20(2016)%20The%20adenosine%20metabolite%20inosine%20is%20a%20functional%20agonist%20of%20the%20adenosine%20A2A%20receptor%20with%20a%20unique%20signaling%20bias.%20Cell%20Signal%2028(6):552%E2%80%93560.%2010.1016/j.cellsig.2016.02.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Zhao H, Zhang W, Lu Y et al (2024) Inosine enhances the efficacy of immune-checkpoint inhibitors in advanced solid tumors: a randomized, controlled, phase 2 study. Cancer Med 13(17):e70143. 10.1002/cam4.70143
</cite> [<a href="https://doi.org/10.1002/cam4.70143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11393481/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39267574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20H,%20Zhang%20W,%20Lu%20Y%20et%20al%20(2024)%20Inosine%20enhances%20the%20efficacy%20of%20immune-checkpoint%20inhibitors%20in%20advanced%20solid%20tumors:%20a%20randomized,%20controlled,%20phase%202%20study.%20Cancer%20Med%2013(17):e70143.%2010.1002/cam4.70143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Nomura M, Nagatomo R, Doi K et al (2020) Association of short-chain fatty acids in the gut microbiome with clinical response to treatment with nivolumab or pembrolizumab in patients with solid cancer tumors. JAMA Netw Open 3(4):e202895. 10.1001/jamanetworkopen.2020.2895
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2020.2895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7163404/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32297948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nomura%20M,%20Nagatomo%20R,%20Doi%20K%20et%20al%20(2020)%20Association%20of%20short-chain%20fatty%20acids%20in%20the%20gut%20microbiome%20with%20clinical%20response%20to%20treatment%20with%20nivolumab%20or%20pembrolizumab%20in%20patients%20with%20solid%20cancer%20tumors.%20JAMA%20Netw%20Open%203(4):e202895.%2010.1001/jamanetworkopen.2020.2895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Coutzac C, Jouniaux J-M, Paci A et al (2020) Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun 11(1):2168. 10.1038/s41467-020-16079-x
</cite> [<a href="https://doi.org/10.1038/s41467-020-16079-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7195489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32358520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coutzac%20C,%20Jouniaux%20J-M,%20Paci%20A%20et%20al%20(2020)%20Systemic%20short%20chain%20fatty%20acids%20limit%20antitumor%20effect%20of%20CTLA-4%20blockade%20in%20hosts%20with%20cancer.%20Nat%20Commun%2011(1):2168.%2010.1038/s41467-020-16079-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Kull B, Arslan G, Nilsson C, Owman C, Lorenzen A, Schwabe U, Fredholm BB (1999) Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochem Pharmacol 57(1):65â€“75. 10.1016/s0006-2952(98)00298-6
</cite> [<a href="https://doi.org/10.1016/s0006-2952(98)00298-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9920286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kull%20B,%20Arslan%20G,%20Nilsson%20C,%20Owman%20C,%20Lorenzen%20A,%20Schwabe%20U,%20Fredholm%20BB%20(1999)%20Differences%20in%20the%20order%20of%20potency%20for%20agonists%20but%20not%20antagonists%20at%20human%20and%20rat%20adenosine%20A2A%20receptors.%20Biochem%20Pharmacol%2057(1):65%E2%80%9375.%2010.1016/s0006-2952(98)00298-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Klysz DD, Fowler C, Malipatlolla M, Stuani L, Freitas KA, Chen Y, Mackall CL (2024) Inosine induces stemness features in CAR-T cells and enhances potency. Cancer Cell 42(2):266â€“282
</cite> [<a href="https://doi.org/10.1016/j.ccell.2024.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10923096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38278150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klysz%20DD,%20Fowler%20C,%20Malipatlolla%20M,%20Stuani%20L,%20Freitas%20KA,%20Chen%20Y,%20Mackall%20CL%20(2024)%20Inosine%20induces%20stemness%20features%20in%20CAR-T%20cells%20and%20enhances%20potency.%20Cancer%20Cell%2042(2):266%E2%80%93282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12364772/bin/262_2025_4111_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (PDF 780 KB)</a><sup> (779.6KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s00262-025-04111-2"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/262_2025_Article_4111.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12364772/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12364772/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364772%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364772/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12364772/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12364772/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40828195/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12364772/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40828195/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12364772/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12364772/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="nbUeeOM8UwDp5JrDb09iz6vc55rYlfnVDyY3CTCP4VYrx1pboaxRJO9KLfjr9DtU">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
